Buscar Company's Subsidiary Armorgenix Appoints Eric Sauer as Chief Operating Officer to Drive Innovation in Natural Health and Pharmaceutical Solutions
BEVERLY HILLS, Calif., Aug. 27, 2025 /PRNewswire/ -- Armorgenix, a subsidiary of Buscar Company (OTC: CGLD), today announced the appointment of Eric Sauer, RPh, DHPh, as its new Chief Operating Off...
How is the market likely to price in this management change and acquisition, and what short‑term price volatility could traders anticipate?
What are the expected financial synergies and cost implications of Buscar's 70% stake acquisition of Armorgenix, and how might they affect CGLD's earnings guidance?
How will Eric Sauer's experience as a pharmacist influence Armorgenix's product development timeline and potential revenue growth?
15 days ago